Since President Trump appointed him to the post of Health and Human Services Secretary in November of 2024, Robert F. Kennedy, Jr., has made a number of health claims at odds with established medical science.

But thus far, these positions have not taken aim at a specific brand, as an announcement due out Monday is expected to.

As reported by the Washington Post on September 21, federal health officials are preparing to publicly suggest a clinical link between acetaminophen use and autism. While it’s unclear if the feds will mention Tylenol by name, they probably don’t need to: Tylenol is practically synonymous with the drug. Its parent company Kenvue tops the $10.4 billion acetaminophen category with a 15% market share, according to data from Global Market Insights.

Depending on how s

See Full Page